Figure 3 — Doxycycline, Azithromycin and Vitamin C (DAV): A potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs)

Research Paper|Volume 11, Issue 8|pp. 2202–2216

Doxycycline, Azithromycin and Vitamin C (DAV): A potent combination therapy for targeting mitochondria and eradicating cancer stem cells (CSCs)

Back to articleFigure 3(3 of 16)

100%

Figure 3.Combination of low-dose Doxycycline and Azithromycin reduces glycolysis and glycolytic reserve. The metabolic profile of MCF7 cell monolayers pre-treated with the combination of 1 μM Doxycycline and 1 μM Azithromycin for 3 days was assessed using the Seahorse XFe96 analyzer. **p < 0.01. DOX, Doxycycline; AZI, Azithromycin.